ScarABEONCT06906237
Scarless Advanced Breast Extended Oncoplasty: The ScarABEO Study
StatusRecruiting
PhaseNot specified
Primary completion (estimated)
At risk: Primary completion moved 2 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 5 versions: 5 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 11 words
- Primary completion pushed from Oct 1, 2026 to Dec 1, 2026
- Study completion pushed from Dec 1, 2026 to Jun 1, 2027
- Notable Primary completion date: Oct 1, 2025 to Oct 1, 2026
- Study completion date: Dec 1, 2025 to Dec 1, 2026
- Minor Primary completion date: Sep 1, 2025 to Oct 1, 2025
- Start date changed from estimate of May 1, 2025 to Apr 18, 2024
- Minor Trial status: Enrolling by Invitation to Recruiting
- Site details revised
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Margin infiltration rate
Timeframe: Perioperative
Secondary (6)
Re-excisions rate
Total resection volume and final breast volume ratio
Post-operative complication rates
Post-operative breast symmetry
Disease-free survival
Show 1 moreShow less
Overall Survival
Sites
1 site in 1 country
- Veneto Institute of OncologyPadova, Italy